WEBINAR: Movilitas.Cloud FMD Solution
on January 17th at 4pm CETRead more
The EU Falsified Medicine Directive has an implementation deadline of February 9th, 2019 and aims to improve patient safety by securing the life science supply chain. The directive enforces every stakeholder of the life science supply chain to be technologically ready to face this looming deadline.
The European Medicines Verification Organisation (EMVO) is the guarantee of patient security in Europe. The EMVO has taken responsibility for advancing the formation of the European Medicines Verification System (EMVS).
The European Medicines Verification System ensures the implementation of a functioning, secure, interoperable and cost-effective system to support the obligations of the different stakeholders of the life science supply chain across Europe. It is the system in which the MAH have to report their product data, which is then further distributed to the different National Systems in the countries in which the products are sold.
Watch below to see how Movilitas and Phoenix worked together to help satisfy FMD requirements by using Movilitas.Cloud as their solution.